Cell IDx’s UltraPlex platform technology provides everything you need for multiplexed IHC-based immune-profiling of tissue biomarkers. One technology from
research to clinical — from staining to analysis in one day.
News & Technology Updates
Cell IDx is pleased to announce the co-authorship and use of our UltraPlex mxIF technology for profiling of the TME in this important study
A Phase I trial assessing the safety and tolerability of a therapeutic DNA vaccination against HPV16 and HPV18 E6/E7 oncogenes after chemoradiation for cervical cancer. View a summary of this paper by
Allows detection of 2–4 markers using primary antibodies from any species employing a single antigen retrieval step on an autostainer.
Phenotype infiltrating T cell subpopulations, B cells, and antigen-presenting cells, and quantitate expression of key molecules including checkpoint markers.
Highest sensitivity and specificity, low background secondary antibody HRP immunopolymers for all your IHC needs.
Custom multiplex panel development , and
section staining and imaging.
- For Research Use Only. Not for use in diagnostic procedures.